Additional testing may be considered for people with a family history of premature heart disease, metabolic risk, abnormal cholesterol results, known cardiovascular disease, or uncertainty after standard testing: ApoB, Lp(a), and hs-CRP may help reveal particle burden, inherited risk, and inflammation that are not fully captured by LDL cholesterol alone
(PubMed) Stop further injections and report the event to the clinic and your national drug safety authority (e.g., FDA in the US, local health regulator)
What This Means for You GLP-1 medications dont replace habitsthey support them
GHK-Cu is a copper tripeptide complex that occurs naturally in human plasma, saliva, and urine
doi: 10.1016/0002-9343(88)90013-7
However, there are emerging indications that employer sentiment may be shifting, as the survey also found that roughly 80% of human resources decision-makers expressed interest in expanding coverage for GLP-1s